World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
139
Citations
91133
World Ranking
1728
National Ranking
990

Scott M. Lippman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Scott M. Lippman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 757 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Scott M. Lippman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Scott M. Lippman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Scott M. Lippman is affiliated with the University of California, San Diego in the United States. Their research primarily lies in the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, and Genetics.

The scientist's main topics of study include:

  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • BRCA gene mutations in cancer
  • Lung Cancer Treatments and Mutations
  • Head and Neck Cancer Studies
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research

Lippman has authored several notable papers, including:

  • "Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy," published in 2020 in Nature Communications
  • "Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial," published in 2021 in The Lancet Oncology
  • "Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus," published in 2023 in Nature
  • "Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test," published in 2022 in Communications Medicine
  • "JAK: Not Just Another Kinase," published in 2022 in Molecular Cancer Therapeutics

Frequent co-authors include:

  • Razelle Kurzrock
  • Shumei Kato
  • Ludmil B. Alexandrov
  • Andrew M. Lowy
  • Anirban Maitra

The scientist has published extensively in several venues, with multiple publications in:

  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Medicine
  • Gastroenterology
  • Cancer Research

Scott M. Lippman has been recognized as a member of the Association of American Physicians. Their work contributes to advancing knowledge within the oncology and cancer research communities.

Best Publications

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • The Influence of Finasteride on the Development of Prostate Cancer

    Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

  • Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

  • Molecular origins of cancer: Lung cancer

    Roy S. Herbst;John V. Heymach;Scott M. Lippman;Scott M. Lippman

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Head and neck cancer.

    Everett E. Vokes;Ralph R. Weichselbaum;Scott M. Lippman;Waun Ki Hong

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

    Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin

  • Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

    Edward S. Kim;Vera Hirsh;Tony Mok;Mark A. Socinski

  • Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

    Waun ki Hong;Scott M. Lippman;Loretta M. Itri;Daniel D. Karp

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

    Libero Santarpia;Scott M Lippman;Adel K El-Naggar

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Statins and cancer prevention

    Marie-France Demierre;Peter D. R. Higgins;Stephen B. Gruber;Ernest Hawk

  • Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity

    Michael S. Ewer;Scott M. Lippman

  • Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.

    Jacqueline Kerr;Cheryl Anderson;Scott M Lippman

  • Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

    Farshid Dayyani;Carol J. Etzel;Mei Liu;Chung Han Ho

  • Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

    Jason K. Sicklick;Shumei Kato;Ryosuke Okamura;Maria Schwaederle

  • Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

    Li Mao;Jin S. Lee;You H. Fan;Jae Y. Ro

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Reuben Lotan
Reuben Lotan The University of Texas MD Anderson Cancer Center
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Xifeng Wu
Xifeng Wu Zhejiang University
Vassiliki A. Papadimitrakopoulou
Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center
Li Mao
Li Mao University of Maryland, Baltimore
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career is diverse, and many allied health roles support and enhance patient care outside of traditional MD paths. For those interested in nutrition, an online bachelor's in nutrition offers flexibility and foundational knowledge in dietetics, public health, and wellness.

Leadership roles in healthcare are also growing in demand. Earning a degree from top online mha programs that are cahme accredited can prepare you for management positions in hospitals and healthcare systems—often completely online.

For registered nurses, advancing your credentials is possible with an rn to bsn online no clinicals, offering schedule-friendly study and the ability to progress without on-site clinical requirements.

Aspiring nurse leaders and practitioners can further fast-track their careers with the fastest msn to dnp program, achieving a Doctor of Nursing Practice online in less time.

Exploring these pathways expands your options in healthcare, whether you’re seeking clinical, administrative, or public health roles.

Best Scientists Citing Scott M. Lippman

Trending Scientists

Recently Published Articles